Aquino got second plunder case, DOJ issues lookout order vs former President, ex-Cabinet members, Sanofi execs




Manila, Philippines – On Friday, former President Benigno “Noynoy” Aquino III were charged with plunder case over the P3.5 billion anti-dengue vaccine scandal.

Aquino, together with his former Secretary Janet Garin, and seven more others involved were charged before the Office of the Ombudsman.

This complaint was second plunder case of the former president, filed by Gabriela members and parents of the children who allegedly died after being administered with Dengvaxia vaccine.

On Saturday, Justice Secretary Vitaliano Aguirre II issued an immigration lookout bulletin order (ILBO) against Aquino, some Cabinet members during his term, and the main Sanofi-Pasteur executives.

The following subjects were under lookout by the immigration: Former President Benigno “Noynoy” Aquino III; former Budget Secretary Florencio Abad; former Executive Secretary Paquito Ochoa;former Health Secretary Janette Garin; Guillaume Leroy; Olivier Brandicourt; Ruby Dizon; Thomas Triomphe’ and Carlito Realuyo.

Aguirre ordered the ILBO as there is a “strong probability” that the mentioned persons may leave the country.

According to DOJ, these individuals, after being listed on ILBO will not be allowed to leave out of the country unless an allow departure order will be secured from Aquirre has been secured.

“We thus deem the issuance of an ILBO against the subject persons prudent in order to at least monitor the itineraries of their flight, travel, and/or whereabouts,” Sec. Aquirre said.

Gabriela and other complainants accused these involved individuals of “Knowingly” acting in bad faith when they started to procure for the controversial anti-Dengue vaccine.

“Respondents acted with evident bad faith as their actions did not only connote bad judgment, but also showed a palpably fraudulent and dishonest purpose to do a conscious wrongdoing for their own personal gain or out of ill motive,” the complaint reads.



Post a Comment

0 Comments